Table 1. General description of the patient cohort, and results of the PCR of HPV, cytology and anoscopy.
| Characteristics | Patients MSM-HIV; n = 140 |
| Mean age; years (± SD) | 37.27 (±8.9) |
| Nationality: Spanish; n (%) | 133 (95) |
| Retired; n (%) | 8 (5.8) |
| Education level; n (%) | |
| University | 73 (52.2) |
| Secondary school | 47 (33.6) |
| Primary school | 19 (13.6) |
| None | 1 (0.7) |
| Median number of partners over previous 12 months (IQR) | 1 (1–6.75) |
| Habitually using condoms; n (%), (95%CI) | 109 (77.9), (71–81) |
| Perianal/genital condylomatosis; n (%), (95%CI) | 42 (30), (20–36) |
| History of condylomas; n(%), (95%CI) | 50 (35.7), (28–44) |
| Median duration of HIV; months, (IQR) | 33 (11–84) |
| Mean VL of HIV (log), (±SD) | 3.83 (±4.33) |
| CD4 (cells/μL), (±SD) | 652.87 (±261.71) |
| CD8 (cells/μL), (±SD) | 1431.07 (±4366.35) |
| CD4 nadir (cells/μL), (±SD) | 356.29 (±246.92) |
| AIDS stage (A3, B3, C); n (%), (95%CI) | 46 (32.9), (27–43) |
| Receiving ART; n (%), (95%CI) | 108 (77), (70–84) |
| Number of months of ART; mean (IQR) | 23.5 (8–80.3) |
| Virological treatment failure; n (%), (95%CI) | 7 (6), (2–10) |
| History of syphilis treated; n (%), (95%CI) | 26 (18.6), (12–26) |
| Other STD; n (%), (95%CI) | 56 (40), (32–50) |
| Latent tuberculosis treated; n (%) | 17 (12.5) |
| Chronic HCV infection; n (%) | 6 (4.3) |
| Chronic HBV infection; n (%) | 3 (2.1) |
| Smoking habit; n (%), (95%CI) | 67 (47.9), (41–58) |
| Ex-IVDA, n (%) | 2 (1.5) |
| Median daily alcohol consumption; (SAU), (IQR) | 0 (0–1) |
MSM: males who have sex with males; VL: viral load; HCV: hepatitis C virus infection; HBV: hepatitis B virus infection; SAU: standard alcohol units; ex-IVDA: ex-intravenous drug abuser; SD: standard deviation; STD: sexually transmitted diseases; IQR (inter-quartile range).